title: Should we prescribe "vasodilating" beta-blockers in Marfan syndrome to prevent aortic aneurysm and dissection?
authors.affiliation: School of Medicine, University of Nis, Nis, Serbia. gkoracevic@yahoo.com
authors.forename: Goran
authors.initials: G
authors.lastname: Koraćević
authors.forename: Dejan
authors.initials: D
authors.lastname: Sakac
authors.forename: Milan
authors.initials: M
authors.lastname: Pavlović
authors.forename: Dragana
authors.initials: D
authors.lastname: Ilić
authors.forename: Miloje
authors.initials: M
authors.lastname: Tomasević
authors.forename: Tomislav
authors.initials: T
authors.lastname: Kostić
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000784:Aortic Dissection / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D001014:Aortic Aneurysm / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D001794:Blood Pressure; D006801:Humans; D008382:Marfan Syndrome / Q000150:complications*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents